What are the AIDS (Acquired Immune Deficiency Syndrome)-defining illnesses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

AIDS-Defining Illnesses

AIDS-defining illnesses are specific conditions that, when present in a person with HIV infection, establish the diagnosis of AIDS, including aggressive non-Hodgkin's lymphoma, Kaposi sarcoma, and invasive cervical cancer, along with 20 other clinical conditions defined by the CDC. 1

Definition and Classification

AIDS is diagnosed in HIV-infected individuals who meet one of the following criteria:

  1. CD4+ T-lymphocyte count less than 200 cells/μL
  2. CD4+ T-lymphocyte percentage of total lymphocytes less than 14%
  3. Presence of one or more AIDS-defining clinical conditions 1

The 23 Clinical Conditions That Define AIDS

Cancers

  • Kaposi sarcoma (caused by HHV-8/KSHV) 2
  • Aggressive non-Hodgkin's lymphoma (including primary CNS lymphoma)
  • Invasive cervical cancer 1

Opportunistic Infections

Fungal Infections

  • Pneumocystis jiroveci (formerly carinii) pneumonia (PCP)
  • Candidiasis of bronchi, trachea, lungs, or esophagus
  • Extrapulmonary cryptococcosis
  • Disseminated or extrapulmonary histoplasmosis
  • Chronic intestinal cryptosporidiosis
  • Disseminated or extrapulmonary coccidioidomycosis

Viral Infections

  • Cytomegalovirus disease (other than liver, spleen, or nodes)
  • Cytomegalovirus retinitis (with vision loss)
  • Chronic herpes simplex ulcers (>1 month duration)
  • Progressive multifocal leukoencephalopathy

Bacterial Infections

  • Mycobacterium tuberculosis (pulmonary or extrapulmonary)
  • Mycobacterium avium complex or Mycobacterium kansasii (disseminated or extrapulmonary)
  • Other species of Mycobacterium (disseminated or extrapulmonary)
  • Recurrent bacterial pneumonia (≥2 episodes in 12 months)
  • Recurrent Salmonella septicemia

Protozoal Infections

  • Toxoplasmosis of the brain
  • Isosporiasis with diarrhea (>1 month duration)

Other Conditions

  • HIV wasting syndrome
  • HIV encephalopathy 1

Epidemiology and Incidence

The incidence of AIDS-defining illnesses varies by CD4 count level:

  • At CD4 counts >200 cells/μL: Tuberculosis, recurrent bacterial pneumonia, and Kaposi sarcoma may occur
  • At CD4 counts 50-200 cells/μL: PCP, esophageal candidiasis, and brain toxoplasmosis become more common
  • At CD4 counts <50 cells/μL: Cytomegalovirus disease and Mycobacterium avium complex infection predominate 3

Impact of Antiretroviral Therapy

The introduction of highly active antiretroviral therapy (HAART) has dramatically changed the landscape of AIDS-defining illnesses:

  • AIDS-defining cancers have declined significantly (Kaposi sarcoma by up to 90%) 1
  • The 5-year survival rate for patients with AIDS-related Kaposi sarcoma improved from 12.1% in the pre-ART era to as high as 88% currently 2
  • Non-AIDS-defining cancers now represent an increasing proportion of malignancies in people living with HIV 1

Clinical Pearls

  • AIDS-defining illnesses may present atypically in HIV-infected patients, especially with advanced immunosuppression
  • Multiple AIDS-defining conditions often coexist in the same patient
  • Non-malignant causes of lymphadenopathy should be considered in people living with HIV 1
  • The risk of developing opportunistic infections increases progressively as CD4 counts fall below 200 cells/mm³ 4

Prevention

  • Early HIV diagnosis and prompt initiation of antiretroviral therapy is the most effective strategy to prevent AIDS-defining illnesses
  • Prophylaxis against common opportunistic infections (particularly PCP and toxoplasmosis) is indicated at specific CD4 thresholds
  • Regular monitoring of CD4 counts helps identify patients at risk for specific opportunistic infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Kaposi Sarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

HIV infection and AIDS.

Papua and New Guinea medical journal, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.